Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VibeX and KXL System for Keratoconus and Corneal Ectasia
NCT01459679Phase 3Terminated
- Sponsor
- American-European Congress of Ophthalmic Surgery
- Start
- Jul 2012
- Primary completion
- Jan 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of riboflavin in keratoconus, corneal ectasia, sponsored by American-European Congress of Ophthalmic Surgery. Started Jul 2012; status: terminated.
02
Drugs
riboflavin
03
Conditions
keratoconuscorneal ectasia
Beyond the preview
Go deeper on NCT01459679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01459679.